You'd think so right plovagurl????
But remember - this is the pathetic farce known as the ASX that we are dealing with (as well as imbecile so called "investors" that barely understand what Telstra & Woolworths do, let alone a biotech company researching cutting-edge cancer immuno-oncology therapies.)
Let me recap: In just the past 4 weeks Imugene has:
* Announced a Clinical Trial Agreement with Merck & Pfizer.
* Obtained S&P admittance into the ASX200.
* Received $6 million in cash (via conversion of 150 million IMUOB options).
* Received FDA IND approval for its second Oncolytic Virus (Vaxinia).
* Received FDA IND approval for an additional Phase 2 clinical trial for HER-Vaxx
Any other biotech company, on any other index in the world (with a comparable share price & market cap to Imugene) would have seen it's share price hit $1.00 as result of all this cumulative news.
Only 1 in 10,000 drug applications receives an FDA IND approval. For Imugene to receive 2 in a single day is truly remarkable.
But here, on this joke known as the "ASX", sitting now at a share price of 52 cents, we are actually 12% BELOW the 59 cents we were at before we received the first monumental news of the Merck & Pfizer agreement???????????
How the hell is that possible?
Are the pathetic leaches trading their shares to make a measley2 cents profit responsible? No, those cretins don't have that much sway in the market. So that must mean that it's institutional/broker driven games that are reducing & capping the share price.
Whatmighthaveben probably hit the nail on the head when he wrote on the weekend that it was coming time for Imugene to leave the ASX and list on the NASDAQ. A company like Imugene with it's priceless IP, current cash reserves of AUD$120 million, and huge pipeline of FDA-approved drug candidates - would be worth at least USD$10 Billion (AUD$14 Billion) ... or AUD$2.30 a share.
Congratulations to Leslie, Paul and the tireless IMU team for today's incredibly amazing news.
- Forums
- ASX - By Stock
- IMU
- Ann: FDA IND APPROVAL FOR ONCOLYTIC VIROTHERAPY VAXINIA
Ann: FDA IND APPROVAL FOR ONCOLYTIC VIROTHERAPY VAXINIA, page-31
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M |
Open | High | Low | Value | Volume |
4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 4542680 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 1675759 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 2598776 | 0.041 |
76 | 6281075 | 0.040 |
31 | 5664241 | 0.039 |
15 | 2789416 | 0.038 |
10 | 1400513 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 1652096 | 8 |
0.044 | 1145733 | 8 |
0.045 | 1715026 | 12 |
0.046 | 1642231 | 7 |
0.047 | 1652765 | 8 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online